Biodesix, Inc. (BDSX) held its third-quarter 2026 earnings conference call on November 5, 2026, at 4:30 p.m. Eastern Time. The Biodesix Q3 2026 earnings call gave investors and analysts a scheduled opportunity to hear from the company’s top executives about the quarter’s results.
Leading the call were Scott Hutton, president, chief executive officer and director, and Robin Harper Cowie, chief financial officer, secretary and treasurer. Chris Brinzey of Westwicke Partners, the company’s investor relations firm, opened the session and introduced the executive speakers.
Quarterly Release and Call Access
Biodesix released its third-quarter 2026 financial results earlier that same day. According to the call introduction, the press release announcing the quarterly results and an audio recording of the conference call are both available in the investor relations section of the company’s website, biodesix.com.
The call was conducted as a recorded event and was open to participants dialing in. A complete transcript of the proceedings was also produced.
Forward-Looking Statements and Non-GAAP Measures
Brinzey noted at the outset that the call would include forward-looking statements. He directed listeners to review the statements contained in the day’s press release as well as the risks and uncertainties described in the company’s SEC filings. Those filings identify factors that could cause Biodesix’s actual events, performance and results to differ materially from the forward-looking statements made during the webcast.
In addition, the call included discussion of non-GAAP financial measures. Descriptions of those measures and reconciliations between GAAP and non-GAAP figures were included in the press release issued with the quarterly results.
Participants and Format
The session followed a standard earnings-call format. After opening remarks from investor relations and management, the operator managed the question-and-answer portion. The operator instructed participants on the procedure for asking questions and noted that the conference was being recorded.
The call’s participant list included research analysts from several firms covering the company. Among those listed were Thomas Flaten of Lake Street Capital Markets, Pradeep Ambrose of TD Cowen, Kevin Holder of ROTH Capital Partners, William Bonello of Craig-Hallum Capital Group, Alexander Vukasin of Canaccord Genuity Corp. and Katherine Degen of H.C. Wainwright & Co.
Biodesix’s quarterly earnings call serves as a regular forum for management to review financial performance and business developments with the investment community. The third-quarter 2026 event followed that established pattern, with the CEO and CFO leading the presentation and taking questions from covering analysts.